Bank: Choose this European company over Lilly
Eli Lilly has raised expectations for 2013 more than anticipated, but one factor especially has the Danish bank Nordea recommending a European company over the US pharmaceutical group.
by Stefan Singh Kailay
In spite of raised expectations for 2013, which exceeded the estimates of most analysts, Nordea does not have a lot of faith in Eli Lilly.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
- Adgang til alle låste artikler
- Modtag vores daglige nyhedsbreve
- Fuld adgang til vores app
.jpg&w=384&q=75){kind=logo}
